Granules India Limited (GRANULES.BO)
INR 600.35
(0.58%)
INR 600.35
(0.58%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 689.71 Million INR | -68.54% |
| 2022 | 2.19 Billion INR | -9.4% |
| 2021 | 2.41 Billion INR | -29.07% |
| 2020 | 3.41 Billion INR | -19.07% |
| 2019 | 4.21 Billion INR | -11.96% |
| 2018 | 4.78 Billion INR | 10.54% |
| 2017 | 4.33 Billion INR | 248.62% |
| 2016 | 1.24 Billion INR | -32.55% |
| 2015 | 1.84 Billion INR | -24.09% |
| 2014 | 2.42 Billion INR | -21.53% |
| 2013 | 3.09 Billion INR | 76.21% |
| 2012 | 1.75 Billion INR | 99.31% |
| 2011 | 880.53 Million INR | -35.84% |
| 2010 | 1.37 Billion INR | -6.45% |
| 2009 | 1.46 Billion INR | -19.99% |
| 2008 | 1.83 Billion INR | 26.71% |
| 2007 | 1.44 Billion INR | 8.28% |
| 2006 | 1.33 Billion INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 689.71 Million INR | -68.54% |
| 2023 Q4 | 689.71 Million INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.84 Billion INR | 0.0% |
| 2022 FY | 2.19 Billion INR | -9.4% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 2.19 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 1.89 Billion INR | 0.0% |
| 2021 Q2 | 2.92 Billion INR | 0.0% |
| 2021 Q4 | 2.41 Billion INR | 0.0% |
| 2021 FY | 2.41 Billion INR | -29.07% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 3.41 Billion INR | 0.0% |
| 2020 FY | 3.41 Billion INR | -19.07% |
| 2020 Q2 | 3.9 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 4.21 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 4.36 Billion INR | 0.0% |
| 2019 FY | 4.21 Billion INR | -11.96% |
| 2018 Q4 | 4.78 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 5.71 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 4.78 Billion INR | 10.54% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 2.52 Billion INR | 0.0% |
| 2017 Q4 | 4.33 Billion INR | 0.0% |
| 2017 FY | 4.33 Billion INR | 248.62% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 1.24 Billion INR | 0.0% |
| 2016 FY | 1.24 Billion INR | -32.55% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q2 | 1.52 Billion INR | 0.0% |
| 2015 Q2 | 2.82 Billion INR | 0.0% |
| 2015 Q4 | 1.84 Billion INR | 0.0% |
| 2015 FY | 1.84 Billion INR | -24.09% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q3 | - INR | -100.0% |
| 2014 Q2 | 3.02 Billion INR | 0.0% |
| 2014 FY | 2.42 Billion INR | -21.53% |
| 2014 Q4 | 2.42 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q2 | 2.23 Billion INR | 0.0% |
| 2013 FY | 3.09 Billion INR | 76.21% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q4 | 3.09 Billion INR | 0.0% |
| 2012 Q2 | 1.73 Billion INR | 0.0% |
| 2012 Q4 | 1.75 Billion INR | 0.0% |
| 2012 FY | 1.75 Billion INR | 99.31% |
| 2011 FY | 880.53 Million INR | -35.84% |
| 2010 FY | 1.37 Billion INR | -6.45% |
| 2009 FY | 1.46 Billion INR | -19.99% |
| 2008 FY | 1.83 Billion INR | 26.71% |
| 2007 FY | 1.44 Billion INR | 8.28% |
| 2006 FY | 1.33 Billion INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 235.2 Million INR | -193.244% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -4837.786% |
| Sigachi Industries Limited | 265.79 Million INR | -159.487% |
| Bal Pharma Limited | 363.82 Million INR | -89.572% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -517.876% |
| Medico Remedies Limited | 8.67 Million INR | -7853.298% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Venus Remedies Limited | 386.8 Million INR | -78.312% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -547.008% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Nectar Lifesciences Limited | 1.4 Billion INR | 50.843% |
| Shilpa Medicare Limited | 5.6 Billion INR | 87.687% |
| Aarti Drugs Limited | 2.75 Billion INR | 74.95% |
| Lupin Limited | 1.55 Billion INR | 55.583% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 96.769% |
| Zydus Lifesciences Limited | 251 Million INR | -174.785% |
| Windlas Biotech Limited | 20.18 Million INR | -3317.79% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Eris Lifesciences Limited | 6.54 Billion INR | 89.462% |
| Valiant Laboratories Limited | 746.63 Million INR | 7.624% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -191.755% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | 34.828% |
| Ipca Laboratories Limited | 5.8 Billion INR | 88.117% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -93.781% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -5085.789% |
| Bajaj HealthCare Limited | 650.34 Million INR | -6.053% |
| RPG Life Sciences Limited | -30.3 Million INR | 2376.271% |
| Mankind Pharma Limited | 248.67 Million INR | -177.352% |
| Laurus Labs Limited | 8.6 Billion INR | 91.984% |
| Piramal Pharma Limited | 24.83 Billion INR | 97.223% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 56679.984% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 95.7% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -9.687% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | 54.532% |
| Unichem Laboratories Limited | 382.22 Million INR | -80.448% |
| Sequent Scientific Limited | 1.42 Billion INR | 51.674% |
| Novartis India Limited | 50.7 Million INR | -1260.375% |
| Wanbury Limited | 820 Million INR | 15.889% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -224.79% |
| Wockhardt Limited | 8.91 Billion INR | 92.259% |
| Themis Medicare Limited | 267.74 Million INR | -157.604% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -812.677% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 97.822% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -367.252% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 88.486% |
| Divi's Laboratories Limited | 20 Million INR | -3348.55% |
| NATCO Pharma Limited | 53 Million INR | -1201.34% |
| Gufic Biosciences Limited | 1.53 Billion INR | 55.203% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Ind-Swift Limited | 10.09 Billion INR | 93.168% |
| Procter & Gamble Health Limited | 68.8 Million INR | -902.485% |
| FDC Limited | 2.46 Million INR | -27868.775% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | 62.414% |
| Medicamen Biotech Limited | 12.55 Million INR | -5393.509% |
| Alkem Laboratories Limited | 400 Million INR | -72.428% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -2377.763% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Brooks Laboratories Limited | 3.56 Million INR | -19246.704% |
| Megasoft Limited | 1.35 Billion INR | 49.176% |
| ZIM Laboratories Limited | 356 Million INR | -93.735% |
| Strides Pharma Science Limited | 6.71 Billion INR | 89.729% |
| Neuland Laboratories Limited | 449.2 Million INR | -53.54% |
| Morepen Laboratories Limited | 33.64 Million INR | -1950.268% |
| Hikal Limited | 4.22 Billion INR | 83.689% |
| Indoco Remedies Limited | 3.51 Billion INR | 80.391% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -172327.5% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -416.478% |
| Hester Biosciences Limited | 1.81 Billion INR | 62.057% |